Colorcon acquires Paulaur Corp.’s pharma sugar spheres business

Emily Bader//January 18, 2016//

Colorcon acquires Paulaur Corp.’s pharma sugar spheres business

Emily Bader//January 18, 2016//

Listen to this article

Colorcon Inc. announced Monday that it has acquired the pharmaceutical sugar spheres business from Paulaur Corp., a Cranbury-based manufacturer of specialty sugar-based ingredients.The addition of Paulaur’s products complete’s Colorcon’s Suglets Sugar Spheres product line and enhances the company’s position as a global supplier of sugar spheres.

“There is strong demand in the (pharmaceutical) industry for a supplier who offers high quality product, application and formulation support with a multifacility business continuity plan. This acquisition complements Colorcon’s existing investment in its people, capabilities, and organization, which have consistently delivered superior products and services to Colorcon’s pharmaceutical and dietary supplement customers,” Pankaj Rege, general manager for Colorcon Manufactured Products, said in a statement.

“Paulaur had made the decision to leave the pharmaceutical and nutraceutical spheres arena in order to concentrate on our fast-growing food and confectionary business. At the same time, we wanted to insure that our pharmaceutical and nutraceutical spheres customers could be assured of a continued availability of quality product. The sale to Colorcon provides our customers with just such a supplier,” Mitchell Stefaniak, vice president and chief financial officer of Paulaur, said in a statement.

“Paulaur’s pharmaceutical sugar spheres business is an exciting strategic acquisition for Colorcon. This announcement comes at the end of another strong year for us, with growth across all business areas. Colorcon views this agreement as an opportunity to expand Colorcon’s sugar spheres business and leverage our global distribution, technical service, and sales infrastructure,” Martti Hedman, CEO of Colorcon, said in a statement.

Financial terms of the deal were not disclosed.